Evidence map›Paper›PMID 11064455›Full record

ArticleOncogene2000

Sp1 and Sp3 activate p21 (WAF1/CIP1) gene transcription in the Caco-2 colon adenocarcinoma cell line.

A L Gartel, E Goufman, F Najmabadi, A L Tyner

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Transcription Factor Sp1 Promotes the Expression of Porcine ROCK1 Gene.International journal of molecular sciences · 2016
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

A L GartelDepartment of Molecular Genetics, University of Illinois at Chicago, 900 S. Ashland Avenue, Chicago, Illinois, IL 60607, USA.
E Goufman
F Najmabadi
A L Tyner
Ashland (United States) · USUniversity of Illinois Chicago · US

Funding

INDUCTION OF P21 AND P27 IN LIVER AFTER CCL4 INJURYR01DK056283 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI TYNER, ANGELA L · 2001 to 2005
$1.3M
REPRESSION OF AFP TRANSCRIPTION IN THE LIVER AND GUTR01DK048836 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI TYNER, ANGELA L · 1995 to 1998
–
NIDDK NIH HHS DK48836NIDDK NIH HHS R01 DK056283
6 · The paper itself

Abstract

The CDK inhibitor p21WAF1/CIP1 is a negative regulator of the cell cycle, and its expression is induced during terminal differentiation in vitro and in vivo. Expression of p21 is controlled at the transcriptional level by both p53-dependent and -independent mechanisms. Our previous studies established that p21 is expressed in the Caco-2 adenocarcinoma cell line, and its expression is induced by a p53-independent mechanism during differentiation of these cells. Here we have found that transcription of p21 in Caco-2 cells is controlled primarily by the transcription factors Sp1 and Sp3 through two Sp1 binding sites, Sp1-1 and Sp1-2, located between -119 and -114 bp and between -109 and -104 bp of the p21 promoter, respectively. Sp1 and Sp3 binding to the p21 promoter increased during Caco-2 cell differentiation, while the absolute level of Sp1 did not change and the absolute level of Sp3 increased approximately twofold. Transfection experiments in the SL2 Drosophila cell line that lacks endogenous Sp3 activity demonstrated that Sp1 transactivates the p21 promoter primarily through the Sp1-2 site, while Sp3 acts through the Sp1-1 site. In these cells Sp3 is a stronger transactivator of the p21 promoter than Sp1. Our data suggest that induction of p21 transcription during Caco-2 differentiation is modulated by Sp1/Sp3 interactions with the p21 promoter.

Indexed as

AdenocarcinomaAnimalsBinding SitesCaco-2 CellsColonic NeoplasmsCyclin-Dependent Kinase Inhibitor p21CyclinsDNA-Binding ProteinsDrosophilaHumansPromoter Regions, GeneticProtein BindingSp1 Transcription FactorSp3 Transcription FactorTranscription FactorsTranscription, GeneticCDKN1A protein, humanCyclin-Dependent Kinase Inhibitor p21CyclinsDNA-Binding ProteinsSp1 Transcription FactorSP3 protein, humanSp3 Transcription FactorTranscription Factors

Identifiers

PMID11064455
OpenAlexW2330179602

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.